Taking semaglutide may lead to a slight increase in heart rate — typically by two to three beats per minute, based on trials sponsored by Novo Nordisk using 0.5 and 1 mg doses of semaglutide.

Compounded semaglutide is a non-FDA-approved alternative to products that contain semaglutide, such as Ozempic. Learn how the safety and efficacy of compounded semaglutide compares with Ozempic.

When it comes to semaglutide, withdrawal symptoms can involve changes related to weight, appetite, blood sugar levels, and cardiovascular health. When you regularly take a medication that alters ...

Almost 200 of the diabetes patients were prescribed semaglutide and 17 went on to develop NAION, a rate more than four times higher than those not prescribed the drug. For the obesity group, 361 ...

Semaglutide treatment was initiated at a dose of 0.25 mg for 4 weeks, and the dose was escalated every 4 weeks until the maintenance dose of 2.4 mg was reached by week 16 (Fig. S1).

Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing neovascular age-related macular degeneration (nAMD) in older patients with ...

If all newly eligible patients received semaglutide, Medicare Part D spending could increase by $34 billion to $145 billion each year, according to new research. Published Aug. 27, 2024 ...

Danish drugmaker Novo Nordisk said on Tuesday it has filed 14 new lawsuits in the United States against the sale of ...

The FDA has removed semaglutide from its drug shortage list after the agency determined the current supply of the drug can meet present and future demand, Novo Nordisk and the FDA announced. On ...

The new study, which was funded by Novo Nordisk, included about 400 patients with knee osteoarthritis, with an average age of 56, in 11 countries. About 80% of the people in the study were women ...